Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

The dog fully recovered one month after treatment.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

High-dose vitamin A and E with zinc improved blood sugar control and insulin function in diabetics, but may cause hair loss.

No medications for alcohol dependence have been approved for marketing yet.

A specific genetic change in the KRT71 gene causes a hair loss condition in Hereford cattle.

Biomimetic scaffolds are better than traditional methods for growing cells and could help regenerate various tissues.

Immune cells are essential for early hair and skin development and healing.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Activin A and follistatin control when ear hair cells form in mice.

Activin A promotes ear hair cell development, while follistatin delays it.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Combining scalp reduction and hair transplants improves coverage and appearance for male baldness.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.